Search result for 'bacterial infections'

Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, including Ibuprofen tablets and Cefixime for Oral Suspension.

Lupin and Eugia, a unit of Aurobindo Pharma, are recalling products from the US market due to manufacturing issues. The USFDA has initiated Class II and Class III recalls for various medications....

Lupin has received USFDA approval to launch generic Doxycycline for Injection and Letermovir Tablets in the US market, targeting a combined annual market value of USD 362 million.

Dr Reddy's Laboratories has launched a generic Doxycycline Capsules (40 mg) in the US market, a therapeutic equivalent of Oracea capsules (40 mg).